Fibrous Dysplasia Mimicking Malignancy on 68Ga-DOTATATE PET/CT.
暂无分享,去创建一个
[1] U. Bagci,et al. Kidney Tumor in a von Hippel-Lindau (VHL) Patient With Intensely Increased Activity on 68Ga-DOTA-TATE PET/CT. , 2016, Clinical nuclear medicine.
[2] U. Bagci,et al. Epididymal Cystadenomas in von Hippel-Lindau Disease Showing Increased Activity on 68Ga DOTATATE PET/CT. , 2016, Clinical nuclear medicine.
[3] U. Bagci,et al. Endolymphatic Sac Tumor Showing Increased Activity on 68Ga DOTATATE PET/CT. , 2016, Clinical nuclear medicine.
[4] Ulas Bagci,et al. Schmorl Nodes Can Cause Increased 68Ga DOTATATE Activity on PET/CT, Mimicking Metastasis in Patients With Neuroendocrine Malignancy. , 2016, Clinical nuclear medicine.
[5] Ulas Bagci,et al. Ectopic ACTH and CRH Co-secreting Tumor Localized by 68Ga-DOTA-TATE PET/CT. , 2015, Clinical nuclear medicine.
[6] R. Hicks,et al. Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation. , 2015, Radiographics : a review publication of the Radiological Society of North America, Inc.
[7] N. Bhattacharyya,et al. Fibrous Dysplasia and Fibroblast Growth Factor-23 Regulation , 2013, Current Osteoporosis Reports.
[8] C. Zoccali,et al. Mazabraud’s syndrome: a new case and review of the literature , 2009, International Orthopaedics.
[9] S. Wientroub,et al. An Instrument to Measure Skeletal Burden and Predict Functional Outcome in Fibrous Dysplasia of Bone , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[10] A. Graham,et al. Imaging findings of fibrous dysplasia with histopathologic and intraoperative correlation. , 2004, AJR. American journal of roentgenology.
[11] F. Czerwiec,et al. Visualization of fibrous dysplasia during somatostatin receptor scintigraphy. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.